Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Adicet Bio (GB:0HX7)
LSE:0HX7
Adicet Bio (0HX7) Stock Price & Analysis
0 Followers
0HX7 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.88 - $21.20
Previous Close$5.88
Volume100.00
Average Volume (3M)254.00
Market Cap
$254.29M
Enterprise Value$17.66M
Total Cash (Recent Filing)$257.66M
Total Debt (Recent Filing)$21.02M
Price to Earnings (P/E)N/A
Beta0.78
Next Earnings
May 15, 2023EPS Estimate
-$0.59Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,589,828
10 Day Avg. Volume18
30 Day Avg. Volume254
Standard Deviation0.26
R-Squared0.05
Alpha-0.00678
Financial Highlights & Ratios
Price to Book (P/B)0.93
Price to Sales (P/S)11.65
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-4.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.71
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.26
Forecast
1Y Price Target
$26.40Price Target Upside349.06% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Adicet Bio News
0HX7 FAQ
What was Adicet Bio’s price range in the past 12 months?
Adicet Bio lowest stock price was $5.88 and its highest was $21.20 in the past 12 months.
What is Adicet Bio’s market cap?
Currently, no data Available
When is Adicet Bio’s upcoming earnings report date?
Adicet Bio’s upcoming earnings report date is May 15, 2023 which is in 48 days.
How were Adicet Bio’s earnings last quarter?
Adicet Bio released its earnings results on Mar 15, 2023. The company reported -$0.72 earnings per share for the quarter, missing the consensus estimate of -$0.28 by -$0.44.
Is Adicet Bio overvalued?
According to Wall Street analysts Adicet Bio’s price is currently Undervalued.
Does Adicet Bio pay dividends?
Adicet Bio does not currently pay dividends.
What is Adicet Bio’s EPS estimate?
Adicet Bio’s EPS estimate is -$0.59.
How many shares outstanding does Adicet Bio have?
Currently, no data Available
What happened to Adicet Bio’s price movement after its last earnings report?
Adicet Bio reported an EPS of -$0.72 in its last earnings report, missing expectations of -$0.28. Following the earnings report the stock price went down -4.359%.
Which hedge fund is a major shareholder of Adicet Bio?
Among the largest hedge funds holding Adicet Bio’s share is RA Capital Management. It holds Adicet Bio’s shares valued at N/A.
---
Adicet Bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$26.40 (349.06% Upside)
$26.40 (349.06% Upside)
Blogger Sentiment
Bullish
GB:0HX7 Sentiment 100%
Sector Average 68%
Sector Average 68%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.58%
12-Months-Change
Fundamentals
Return on Equity
-23.44%
Trailing 12-Months
Asset Growth
-2.43%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Adicet Bio
resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.
---
---